ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR-22.0%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-22.0%/yr
Annual compound
Percentile
P79
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 17.95% |
| 2024 | 11.50% |
| 2023 | -3.99% |
| 2022 | 37.77% |
| 2021 | -59.68% |
| 2020 | -14.56% |
| 2019 | -21.27% |
| 2018 | -52.84% |
| 2017 | 18.80% |
| 2016 | -21.08% |